{"title": "I'm making my entire portfolio MSFT and AAPL. Where will I be in 5 years?", "selftext": "This is a hypothetical question.  If I put my entire portfolio in just MSFT and AAPL will I beat the sp500 in 5 years?\n\nI realize there's really no way to know, but what would be your guess?\n\nI think that I probably would, but it's hard to tell.\n\nWhat if I added 2 more stocks like.\n\nMsft aapl hd unh. \n\nI'd increase my diversity a little, but I'm not sure if my returns would be better or worse than just having MSFT and AAPL.\n\nAnd I guess a lot would depend on the overall market correct?\n\nI mean the whole market could sell off for the next 5 years.  You never know.", "id": "mv4s98", "created_utc": 1618966382.0, "score": 10, "upvote_ratio": 0.63, "num_comments": 60, "comments": [{"body": "It‚Äôll definitely move to the right.", "score": 70, "replies": [{"body": "ü§£", "score": 2, "replies": []}]}, {"body": "At this rate you might as well set up recurring investments into the QQQ", "score": 21, "replies": [{"body": "What do you mean?", "score": 0, "replies": [{"body": "Look it up", "score": 0, "replies": [{"body": "I meant what you mean by \"at this rate you might as well\" statement.\n\nMy portfolio is more than just tech.", "score": 2, "replies": []}]}, {"body": "Actively managed ETF by Invesco with its top holdings in Apple and Microsoft", "score": -4, "replies": [{"body": "It's not active", "score": 11, "replies": []}]}]}, {"body": "Or TQQQ", "score": 1, "replies": []}]}, {"body": "[deleted]", "score": 37, "replies": [{"body": "Based on the recent tagline trend, I'm quite certain that the point of this post isn't to give or have someone give you financial advice.", "score": 3, "replies": []}, {"body": "Discussion", "score": 2, "replies": []}]}, {"body": "[deleted]", "score": 8, "replies": [{"body": "Or at least diversify with ETF/Mutual Funds", "score": 2, "replies": []}]}, {"body": "MSFT was mostly *flat* for 12 of the previous 15 years.  \n\nIf that repeats, how happy would you be?", "score": 14, "replies": [{"body": "True. I bought them in 2006 because I thought it was a steal.  Was up like a buck in 2008...lol.  Thankfully, I‚Äôm both hardheaded AND a reeeetard", "score": 2, "replies": [{"body": "I was in *long* before... as they say, don't invest money you need. \n\nWas *barely* satisfied by dividend. But now it's almost $200/ profit. (Just paper)", "score": 1, "replies": []}]}, {"body": "Yes but things have changed. Why are AAPL and MSFT the majority of most indexes?", "score": 1, "replies": [{"body": "[deleted]", "score": 4, "replies": [{"body": "I own a little UNP, but am not abandoning tech and semi equipment.\n\nSemiconductors ARE UBIQUITOUS and not going away any time soon.\n\nI also don't see fangam names going away any time soon.\n\nI've also got 5% in both UNH and HD.", "score": 1, "replies": []}, {"body": "6k shares in XOM ready for it to go back above $70 per share", "score": 1, "replies": []}]}, {"body": "And nothing is static, they can change back. \n\nAlways be prepared to reasess", "score": 1, "replies": [{"body": "I am.  Hypothetical.  I have 5% in each stock.  20% is msft aapl though.\n\nHere's some of my portfolio.\n\nMsft aapl pypl crwd SQ HD UNH total market tmo ASML lrcx wmt SHW", "score": 2, "replies": []}]}]}, {"body": "*laughs in selling covered calls*", "score": 1, "replies": []}, {"body": "Sure but they also were managed by Steve Ballmer", "score": 1, "replies": [{"body": "Still gets no cap gains.... He's not the only CEO with that ability!", "score": 1, "replies": []}]}]}, {"body": "I‚Äôd go apple and google", "score": 4, "replies": [{"body": "I started adding to partial shares of GOOGL last week with $500 in my IRA.  I'm going to try and average down a little if we correct a little.", "score": 2, "replies": []}]}, {"body": "Apple over Microsoft.  Apple still has growth potential (ARM cpus, autonomies driving). Microsoft cloud seems growing now, but doubt about future growth.", "score": 5, "replies": [{"body": "Asml and LRCX have done better than both for many years.", "score": 1, "replies": [{"body": "I'm in high-tech, but never invest in either of them. Maybe it's time to look into them.", "score": 1, "replies": [{"body": "Semiconductor equipment", "score": 2, "replies": []}, {"body": "It amazes me more people haven't heard of asml they effectively have a monopoly on high end chip production.", "score": 1, "replies": [{"body": "Don‚Äôt mean not knowing ASML or LRCX, just not into semi equipment companies. More on companies like TSMC, etc. that uses their equipments.", "score": 1, "replies": []}]}]}]}]}, {"body": "In a better place than you are today.\n\nHonestly with growing focus on privacy and tech, Apple is set up to be king of the world, especially as they build their own chips with embedded AI capabilities.  A lot of the compute will now happen directly on the device.  They‚Äôre already a closed loop system.  And other tech has far more (intentionally or unintentionally) invasive practices.", "score": 6, "replies": []}, {"body": "i‚Äôm voting still working at Wendy‚Äôs.", "score": 11, "replies": [{"body": "That's McDonald's.  I'm the head burger maker.", "score": 4, "replies": []}]}, {"body": "Look at the last 5 years of each. Use that as an idea, but remember that anything can happen. \n\nCovid. Material shortages. Scandalous activities (WYNN)‚Ä¶ nothing is out of the question.", "score": 3, "replies": []}, {"body": "[deleted]", "score": 6, "replies": []}, {"body": "Buy QQQ", "score": 2, "replies": []}, {"body": "Or u could just split it up MSFT AAPL SPY", "score": 2, "replies": []}, {"body": "ASML and LRCX have both outperformed MSFT for many years!  Maybe I should bring them to 5% in my portfolio.\n\nLRCX seems like a good value compared to ASML though.\n\nThoughts?", "score": 2, "replies": [{"body": "Agreed with asml, amazing company that is perfectly positioned right now.", "score": 2, "replies": [{"body": "As is LRCX.  I just divide between the two in my ROTH.", "score": 1, "replies": []}]}]}, {"body": "At this point their massive values might limit their potential upside. And past performance doesn't predict future etc.\n\nIt's much better than two randomly chosen companies, for sure. They are great and hugely profitable businesses. But it's impossible to say if they will over/underperform the market over the next 5. Also with so little diversification, maybe one of those will do great and the other one stagnates, eating all the sweet growth. I would definitely go for a fund that holds those two, but also other things. (And I have.)", "score": 2, "replies": [{"body": "Thanks", "score": 1, "replies": []}]}, {"body": "Up", "score": 2, "replies": [{"body": "Thanks.  That's my hope!", "score": 1, "replies": []}]}, {"body": "I remember back in the 90‚Äôs when everyone said Nortel was a sure thing and would never fail.", "score": 2, "replies": [{"body": "Can't compare the two! Msft is on every computer.", "score": 2, "replies": [{"body": "I‚Äôm just saying nothing is a sure thing with management change.  Who knows what happens in 5 years.", "score": 2, "replies": [{"body": "Right.  Thanks", "score": 1, "replies": []}]}]}]}, {"body": "In all seriousness, the 4th industrial revolution is upon us and there remains to be a lot of a world unseen that will be brought to us by these two behemoths.", "score": 2, "replies": []}, {"body": "rich", "score": 1, "replies": []}, {"body": "Imo aapl is dead, they've created and they're the best at it coming from a android and windows user. Unless they expand into different areas I can't see them growing hugely, there's the rumour that they're going to create a car, if they do then that should boom and bring the stocks to crazy highs. Think it's be better off in a index fund than in Microsoft as they are pretty much flat, you'll get more from a index fund.", "score": -3, "replies": []}, {"body": "I‚Äôm all in dogecoins.   See you in 5 years.  In my Lambo\n\n\nEdit I left out the /s", "score": -13, "replies": []}, {"body": "at some point APPLE/MSFT become XOM so be quite careful.", "score": 1, "replies": [{"body": "Wrong bud! I'm 48.  I'll be dead by then.", "score": 2, "replies": []}]}]}
{"title": "NVAX - Likely my last update DD before reaching Callhalla", "selftext": "I've made a few posts before this ( [1st Post](https://www.reddit.com/r/wallstreetbets/comments/lq3ksw/nvax_dont_miss_this_perfect_vaccine_play_headed/),  [2nd Post](https://www.reddit.com/r/wallstreetbets/comments/luuige/nvax_part_ii_last_call_before_a_shit_ton_of/), [3rd Post](https://www.reddit.com/r/wallstreetbets/comments/mlielu/nvax_i_liked_it_at_300_i_love_it_at_180/)) but I know it's alot to go through so I shall give a brief comprehensive summary here. Just a reminder none of this is financial advice, I am but a mere PhD student that has had the ride of their lives on this stock. My goal isn't to shill or hype but instead to sharpen the conviction of my fellow big-cojone'd NVAX bulls, to concentrate info from different sources, and to create a space for discussion and overleveraged speculation. I think this stock is done taking a shit, we have a good idea of lower bound supports, and we're ready to blow some loads with upcoming catalysts. I also have some current questions I'd like to get the input of the community on. So let's dig in!\n\n**1) Why I believe in the technology**\n\nReally recommend my first post for a more in-depth discussion on this but basically this vaccine is antigen-based which is a very standard tried-and-true modality often used in \"traditional\" vaccines like flu vaccines etc. What makes them special is they add a natural compound (an \"adjuvant\") that makes your immune system super responsive to the antigen. This adjuvant is actually a saponin that is harvested from soapbark trees that grow in Chile. The benefit of using this is that 1) old people and people with weak immune systems respond well and build immunity even with lower doses of antigen 2) you can make vaccines with small amounts of antigen which makes them much cheaper and MOST IMPORTANTLY 3) you can \"fit\" more antigen varieties into a single dose. There's only so much antigen you can inject into a person at once so with this technology you can have a single vaccine with flu AND several covid variant antigens as opposed to having to get a separate vaccine for each virus. Also since this vaccine is protein antigen based you can keep it at 4C (same temp you keep your beers) for months.\n\nAdditionally!!!!! We've seen alot of AMAZING efficacy and safety results from the UK and SA phase 1/2/3 trials and the US phase 1/2 trial (still waiting for phase 3 data to drop soon!). **This is one of the main reasons I remain so bullish.** The humongous unknown risk of efficacy/safety has been largely cleared and now we're just sifting through some other issues/bottlenecks/FUD that I will talk about below. Anyone that trades biotech stocks knows that safety/efficacy are the BIGGEST risk that can curb stomp a stock and we've cleared that in my opinion.\n\n&#x200B;\n\n**2) A brief history of this chart**\n\nThis is one of the wildest charts you'll find and I think it's incredibly important to understand what caused it to look like that so that you can get a better picture of where we're going.\n\n**Sept 2016** \\- Plummet from \\~$150 to \\~$25 came from their RSV vaccine getting poor efficacy results\n\n**Feb 2019** \\- Plummet from \\~$40 to \\~$10 came from them failing the RSV efficacy trials again lmao. HOWEVER things are looking up for RSV vaccine recently (this deserves its own DD honestly but you can read more about it [here](https://www.novavax.com/our-pipeline))\n\nAt this point you can see why investors had no faith in NVAX. It was beaten down like a rabid dog like Ziptrader Charlie would say. Enter covid left stage:\n\n**May 2020** \\- Gap up from \\~$15 to \\~$40 came from A) fantastic nano-Flu phase 3 results (their very own flu vaccine, shown to be better than the current state-of-the-art flu vaccines) which is basically their first big WIN and B) beginning of clinical trials for covid vaccine.\n\n**Aug 2020** \\- Gap up to $180 came from great phase 1/2 covid vaccine results! I remember these glory days. Too bad we then plummeted and became range bound in the $80-$100 range. This was caused by a combo of sell-the-news and competitor companies (MRNA, BNTX, JNJ, AZN) making fast progress.\n\n**Feb 2021**  \\- Gap up to $300 from phase 3 interim data coming from UK phase 3 trial. This was fantastic news! Best in class vaccine with stellar safety and 96% efficacy against original variant. \n\n**Mar 2021 - Present** \\- We fell from grace and have been bouncing between $170 and $220. Lots of factors here but of course the March market madness did not help this low float stock. I vividly remember NVAX falling 10+% day after day during the worst of it. I kept buying the dip and now I'm jacked to the MF tits and not ready to sell even when we get nice 13% days here and there.\n\nNotice anything so far about this chart? **It loves to gap up**. This is a low float stock and the market cap is comparably small compared to competitors like MRNA, JNJ, etc. It's not uncommon to see it almost double when BIG catalysts drop and trust me when I tell you we've got ALOT of big catalysts on the menu. We've recently found a ROCK HARD floor at $170 and most recently a very strong support at $200. This stock has been severely de-risked and I think right now is still a damn good time to buy because of this asymmetrical risk.\n\n&#x200B;\n\n**3) Fear, Uncertainty, and Doubt - Bear case and the FUD spread by short sellers**\n\n\\-*NVAX is too late to the game. The entire world is vaccinated already. Pandemic is over.* This is obviously not true and I've written extensively about it in my 2nd and 3rd posts. India, home to 1.4 BILLION people has only vaccinated a little more than 1% of its vaccination. India is currently the epicenter of the pandemic with cases going parabolic recently sadly. It should also be noted that NVAX has a [deal](https://ir.novavax.com/news-releases/news-release-details/novavax-announces-memorandum-understanding-gavi-cumulative) with the Gavi Institute in India to manufacture and deliver 1.1 Bn doses of covid vaccines. More on India a little further down the post. Additionally, new variants continue to pop up and it seems more and more like we'll be getting covid booster shots for a while.\n\n\\-*Insiders are selling so they know something is up*. This is so stupid don't fall for this trap. They've sold days before major catalysts in the past. Everything is scheduled ahead of time and from what I understand also has something to do with them exercising their options. Let's not even mention the fact that selling millions in stock right before you drop horrible news would be the most blatant illegal insider trading ever lol\n\n\\-*NVAX is having manufacturing issues. They're not gonna be able to produce the vaccines they promised, just look at what happened to the EU deal.* I wrote about this alot in my 3rd post. I was worried at first that the raw materials they were missing perhaps was the adjuvant that comes from the soapbark trees (yikes!) However, as it turns out [the problem is actually the supply of 2,000 liter plastic bags](https://www.fiercepharma.com/manufacturing/lack-grow-bags-a-hefty-problem-for-novavax-s-covid-19-vaccine-production-push) that they need to grow their cells. The bags exist but they're currently being locked up by the US as per the Defense Production Act. Literally the US is reserving the bags for Pfizer and now the institute in India that is supposed to produce a ton of the NVAX vaccines does not have access to them. However the CEO of the institute has [publicly pleaded for Biden to lift the embargo](https://twitter.com/megtirrell/status/1383129792292167680) and it seems like their may be [some action here soon](https://twitter.com/Cold_Peace_/status/1384537640322674689) especially given the dire COVID situation in India. I honestly have no fucking idea what will happen and this is simply what I have gathered in my investigative work across sources. Any clarity or insight here is super appreciated. I don't even know if these bags are reason NVAX was having manufacturing issues for the EU. Regardless, GSK is making some of the NVAX vaccine soon and they should have some stockpiled already at least for the UK and early approvers.\n\n\\-*NVAX US phase 3 trials must have had bad results that's why they haven't released the data yet.* I saved this one for last because it's the most unlikely one in my opinion. I'd be surprised to see repeatedly stellar results in US phase 1/2, UK phase 1/2/3interim/3final trials only to see something worse than JNJ's 66% efficacy in the US/Mexico phase 3 trial.\n\n&#x200B;\n\n**4) Catalysts and Questions for y'all**\n\nOK this is where I summarize what I think will happen soon and also where I need input from y'all. NVAX has completely left us bagholders (oops, I mean investors) in the dark on some of these expected dates and it has been the source of [much strife in twitter comments](https://twitter.com/Novavax/status/1384489266483433472) against the leadership and PR team of NVAX. Not gonna lie they can learn to market and pump themselves more but I appreciate their hardwork on getting the science done well regardless.\n\n**A) Filing for UK Approval**\n\n\\-From what I understand NVAX has already begun the rolling review by the UK MHRA and EU's EMA. They have provided the interim data for UK phase 3 at least and they hopefully have also submitted the finalized UK phase 3 data at this point but I do not know. \n\n\\-Another thing they need to submit is a CMC package. This basically is evidence they provide these regulatory agencies that their manufacturing process is robust and can produce consistent vaccine batches. I have NO idea what the status is with this (did they finish it already?) and any insight is appreciated.\n\n\\-I can only imagine they'd make an announcement when they actually file in the UK but who knows. I also am curious to know how long after filing we can expect to see approval. My hope is that this whole process will be done and the vaccine will be approved by the [end of April](https://www.reuters.com/article/uk-health-coronavirus-britain-vaccine/novavax-covid-19-vaccine-could-be-approved-by-uk-in-april-evening-standard-says-idUSKBN2BM1IF).\n\n\\-Guidance on this could literally drop any day this week or next week and I'm willing to bet we'll gap up on the news as always. As soon as it's approved by the UK then Canada, Australia, and New Zealand will likely follow suit.\n\n**B) US Phase 3 results**\n\n\\-I'm super excited this is gonna be fucking awesome\n\n\\-US/Mexico Phase 3 trials started much later than the UK phase 3 trials. People were concerned for a long time that it would take a ton of time to get results. Even NVAX executives were saying that they were gonna swing for the fences and see if the US FDA would consider an EUA just with UK data instead of having to wait for US data. \n\n\\-Turns out there were tons of willing participants and the trial got 25,000 people signed up in record time. Additionally, waves of covid caused collection of endpoints to happen much faster than expected. TODAY they started crossover trials. This basically means that people that had received the placebo get the read vaccine and people that got the real vaccine get the placebo (they are all still blinded). What is significant about this is that [THEY WOULDN'T DO THE CROSSOVER WITHOUT FIRST GETTING ENOUGH ENDPOINTS TO FILE FOR AN EUA](https://twitter.com/NayeemTheDream/status/1384265587770023942?s=1001).\n\n\\-We basically were all but explicitly told that US phase 3 is complete and the data/news can drop any day now. Put on your spacesuits.\n\n**C) US FDA filing**\n\n\\-NVAX is [aiming for May](https://www.fiercebiotech.com/biotech/novavax-targets-may-approval-for-covid-19-vaccine-u-s). \n\n\\-Again, I have no idea what the status is on the CMC package for the US filing and any insight is welcome.\n\n\\-There are some [interesting speculations on twitter](https://twitter.com/Biohazard3737/status/1384595862202896385) but I have a hard time making sense of them. Take it with a grain of salt as this guy/gal says him/herself.\n\n**D) EU Deal**\n\n\\-The EU deal fell through last month but it seems like it could be getting revived soon. They are facing pressure after the AZN shitshow. \n\n\\-This would be an awesome catalyst but don't hold your breath these EU chiefs are slow AF and seem to be generally fumbling oftentimes when it comes to securing doses for their populace\n\n&#x200B;\n\n**5) My positions and good ways to play this**\n\n\\-My positions are all in on $200c 5/21 options. Like literally my whole portfolio. I don't know that I would recommend this approach for most, the IV on these options is insanely high. I do, however, expect the IV of these options to expand following one of these catalysts. I know this is the opposite of what we typically think of with IV crush following binary events. However, I think the stock is exceptionally undervalued and I DO NOT think approval has been priced in. The majority of the gain will hopefully come from intrinsic value from the calls going deep ITM but I also hope to get an IV bump as people realize that this company has a rich future ahead of it and the call options gain demand. It has been an absolutely wild ride but I'm comfortable to say I now understand the true meaning of diamond hands.\n\n\\-Shares of course (or LEAPS) are godly if you have that sort of capital. Then you can just hang on for a long time. I will definitely switch to LEAPS after this immediate saga is over. I think once NVAX starts actually making a revenue it will absolutely blow earnings out of the park.\n\n\\-If you want to take advantage of high IV then of course theta gang strategies are nice. I caution against selling calls, this stock is ready to pop. Selling puts is a good strategy though you'll miss out on the extra tendies if they go parabolic. I severely caution against close expiration put credit spreads even though they are bullish because this stock CAN be squirrely and drop 10% in a day. If your spreads close OTM you can lose it all.\n\n&#x200B;\n\nStay fresh and see y'all on the moon!", "id": "mv42aw", "created_utc": 1618963804.0, "score": 32, "upvote_ratio": 0.69, "num_comments": 64, "comments": [{"body": "DD posts like this want me to go long on $Adderall", "score": 16, "replies": [{"body": "Having said that screw it, I‚Äôm in.", "score": 8, "replies": []}, {"body": "You can... buy takeda (they own Vyvanse and adderall XR)", "score": 4, "replies": []}]}, {"body": "Been bullish since $3.50 in October 2019. \n\nThis is the way", "score": 7, "replies": [{"body": "November 2019 $5 when my brokerage allowed me to buy", "score": 4, "replies": []}, {"body": "Wow! You‚Äôre in store for a 100-bagger even with non-leveraged shares.", "score": 3, "replies": []}]}, {"body": "I‚Äôm still playing this. I sold out on the most recent pop to $220. My bet is that NVAX bumbles around between $200-$220 before the release of interim US/Mexico data. \n\nIt‚Äôs historically taken the NVAX longer than expected to release trial results. I think it might be 2-3 weeks yet before we get news. That‚Äôs was the case with the UK study. There were tons of people trying to model the release date. \n\nJust to offer a reason that results couple come later than anticipated: they may be starting the crossover study because they know it will take a long time to actually administer the crossover and they are loosing people to other vaccines (you can drop out of you have access to another vax and they have to unblind you). \n\nI would be concerned holding 5/21 calls. \n\nI‚Äôm loading up on shares and 7/16 $250 calls and anywhere between 200-400 shares (selling at local max, buying at local min)\n\nI was wrecked on the tumble from $300 to $150 so I‚Äôm cautiously building my position back up.", "score": 5, "replies": [{"body": "Fantastic insight! This is incredibly helpful and totally seems about right time-wise. I had switched to 5/21 calls to increase my leverage when we were crawling out of the pit of despair. I will cash those out if we get a nice bump to $220-230 again and then buy back in with July calls.", "score": 4, "replies": [{"body": "Did you cash out? That bump may not materialize.", "score": 2, "replies": [{"body": "No, still holding all my 5/21 calls. Plan is to hold until next Friday. Hoping for an end of month PR on Thu. If it doesn‚Äôt come it doesn‚Äôt come :/ I‚Äôll then roll out to July and probably have to take a hit on my total delta but that‚Äôs showbiz baby", "score": 1, "replies": [{"body": "I hope you didn‚Äôt roll. Look at it go.", "score": 2, "replies": [{"body": "I am still holding strong and haven‚Äôt rolled! Hoping for some news still!", "score": 1, "replies": [{"body": "Omg dude it‚Äôs up to 257$. I took some profits. But who knows maybe they have news for today.", "score": 2, "replies": [{"body": "I still think Thursday is a likely day for news. They historically have released big news on Thu (coupled with a NYT article). If not I still believe one of these catalysts will drop within 2 weeks. I do still plan to roll out on Friday though.", "score": 1, "replies": [{"body": "I might buy some weeklies. I‚Äôve partially recouped my losses on this run up.", "score": 1, "replies": [{"body": "I‚Äôd be cautious with weeklies just bc the IV is so insanely high that the premiums are crazy expensive (especially after this run). Makes your breakeven price super high and theta decay killer. Maybe you can do debit spreads if you want to play weeklies?", "score": 1, "replies": [{"body": "Whelp", "score": 1, "replies": []}]}]}, {"body": "Whelp", "score": 1, "replies": []}]}]}]}]}]}]}]}]}, {"body": "How do you not mention that this will be the first vaccine in US that it not based on genetic mechanism? All the vax-hesitant ppl that are forced to get it by their employers! Schhols, etc. will want Novavax over all the others.", "score": 4, "replies": [{"body": "I did mention it‚Äôs more like a traditional vaccine but I should have been more clear! Absolutely this is a huge plus. Lots of hesitancy especially in Europe where their main option is AZN.", "score": 1, "replies": []}, {"body": "\"forced to get it by their employers\" \n\nin the US? lol", "score": 1, "replies": []}]}, {"body": "Nicely done, your DDs are impeccable and greatly underappreciated on this sub. I work in biotech and I have been using NVAX to undo basically all of my other stupid decisions. I agree with the conservative approach they're using, did not know the adjuvant was freaking saponin. Additionally, their BV/Sf9 system would probably be a lot cheaper to scale than some high resource HEK293 system that J&J/AZN use for adenovirus production.\n\nUnfortunately could only afford 280 5/21 calls but I'll take what I can get if the PREVENT-19 results are out, I forsee a fairly good spike given that people like high efficacy numbers.", "score": 4, "replies": [{"body": "Thanks! Nice to hear from someone in the industry. I think yesterday‚Äôs price action is just a show that we‚Äôll reach 300 easily with approval news. I think we‚Äôd get a nice bump from prevent-19 results too! Best of luck out there, hold strong!", "score": 2, "replies": [{"body": "When do you think the approvals are coming? Are you still holding? I am at least until 300. Do you think with approval news it‚Äôll go beyond its ATH at 330? Follow your posts all the time - thanks for your contributions.", "score": 2, "replies": [{"body": "I am definitely holding at least until one of the approvals comes through! And I think after yesterday I am fully convinced that an approval would likely send us past $330 but I have no idea how much further.\n\nI think we can expect some PR today or tomorrow after hours announcing either \n1) US phase 3 results \n2) completed filing of EUA for UK \n3) completed filing of EUA for S. Korea\n4) completed filing of EUA for US\n\nI don‚Äôt think NVAX would announce an EUA approval. I think the FDA (or MHRA for UK) would announce the approval as soon as they come to a decision. That being said I think UK, US, or S. Korea filing are VERY likely to happen by the end of next week. And I think approval would likely come 1-2 weeks after that. Just my guesses based on what we‚Äôve seen before! Hang on for dear life this is a BUMPY ride", "score": 2, "replies": [{"body": "Thank you - this is great motivation.", "score": 1, "replies": []}]}]}]}]}, {"body": "My biggest issue with NVAX is that these guys are slow compared to Moderna/Pfizer...granted Covid isn‚Äôt going away anytime soon but NVAX has executed at a snail‚Äôs pace compared to its peers on the vaccine front :(", "score": 5, "replies": [{"body": "Maybe slow is good. Seems the others rushed it and now people are getting blood clots", "score": 2, "replies": [{"body": "10s of people... out of millions. I can‚Äôt believe that shit even made the news.", "score": 6, "replies": [{"body": "Unless I'm mistaken, it was 6.\n\nI haven't seen 10's anywhere.", "score": 3, "replies": [{"body": "Didn‚Äôt wanna undersell it, lol", "score": 2, "replies": []}]}]}, {"body": "We all know the tale of the snail and the hare... The hare bled out from the blood thinners", "score": 1, "replies": []}]}, {"body": "Yeah NVAX technology takes about a month extra to develop a novel vax when compared to MRNA or PFE. HOWEVER, I do think NVAX has a clear head-start on developing a variant vaccine or a flu+covid vaccine. They are starting SA variant trials this summer and in theory they only have to demonstrate safety which is much faster as far as data collection goes. Additionally, they are starting Flu+covid trials this Fall/Winter and they have the massive advantage over MRNA and PFE that they actually have a standalone Flu vaccine already with great efficacy. Finally I think mRNA-based vaccines are running into dose-limitation issues making it hard to make a booster with many variants in it.", "score": 1, "replies": []}, {"body": "It‚Äôs not about who dose it first... it‚Äôs who does it right. \n\nNVAX will be the preferred product all said and done", "score": 1, "replies": []}]}, {"body": "This is $500 all day. 70 million shares. Low float.", "score": 2, "replies": []}, {"body": "I'm greased up on these tendies so far.", "score": 2, "replies": []}, {"body": "[deleted]", "score": 2, "replies": [{"body": "I think a combo of factors!\n\n1) People are expecting UK approval and US phase 3 EUA submission any day now\n\n2) PFE issue with Myocarditis\n\n3) India receiving supplies from the US to manufacture NVAX\n\n4) S. Korean president meeting with CEO and establishing a task force to submit for EUA in Korea by end of April\n\n5) Prob most significantly was Biden mentioned NVAX in his press conference! He said it was ‚Äúcoming up‚Äù\n\nI‚Äôm still holding lol I think it will run with this momentum and I refuse to sell before news of an approval drops bc I think that will still push this higher", "score": 2, "replies": []}]}, {"body": "Bro, you‚Äôre about to be rich as fuck.  I only got 52 shares but I‚Äôm happy for you man, congrats on calling this.", "score": 2, "replies": []}, {"body": "\\-17% since first post [https://www.markovchained.com/assets/view/NVAX?username=jardinero\\_de\\_tendies&platform=reddit](https://www.markovchained.com/assets/view/NVAX?username=jardinero_de_tendies&platform=reddit). It's gonna need to *really* deliver on the vaccine to turn positive imo.", "score": 1, "replies": [{"body": "Like I said it has been crazy!! I do think it‚Äôll easily make it past $300 with UK approval. This stock is super low float it‚Äôs insane. The other day we were up 13% just bc JNJ had been recalled.", "score": 1, "replies": []}]}, {"body": "[deleted]", "score": 1, "replies": [{"body": "Absolutely! We‚Äôre seeing alot of hesitancy especially in the EU and UK where the main option is AZN. I think this is turning up the pressure to approve NVAX.", "score": 1, "replies": []}]}, {"body": "Bear case: 1. The thing about being late to the market is that everyone else already has contracts for SUPPLIES needed for the vaccine production. And those supplies are also finite, as in producers of those supplies can't just stomp production facilities out of the ground overnight. 2. Biden is thinking lifting the IP on vaccines. That would be a smart move because once the US is vaccinated, the biggest danger will be MUTATIONS, so the faster we get rid of this thing globally, the better for EVERYONE. Obvs. he would only do that after the US is vaccinated. Who will be punished the most? Those late to the party.\n\nAnd yes, NVAX tech might be better for mutations/booster shots, so that's a bull case again. NOT saying any of those are necessarily going to happen, just don't fool yourself thinking this is a sure thing. Just saying it so you can weigh risk accordingly. I have no beef in this, I already closed my position at a small profit.", "score": 1, "replies": [{"body": "These are super good counterarguments. We kind of already are seeing the supply chain issue with the plastic bag shortage. Could affect them longer term but I think alot of these near-term catalysts are still on the menu. \n\nAlso the IP thing is quite ridiculous imo. I know people are quick to support it bc it seems like a noble thing to do. But what you end up doing is disenfranchising the companies that developed the vaccines. It‚Äôs like an anti-incentive for innovation. If we want to be noble how about paying for vaccines and shipping them to countries in need? Regardless I think that this IP thing has a slim chance of pulling through.", "score": 3, "replies": []}, {"body": "It‚Äôs a sure thing if you understand the science", "score": 2, "replies": [{"body": "So how does the science disarm both of my bear cases again? Does it make supplies needed to produce vaccines magically available?", "score": 1, "replies": [{"body": "The science says that NVAX has a superior product, is not mRNA based, doesn‚Äôt have the supply chain issues and freezing issues, and will be the preferred product downstream + they have nanflu rolling out which will also become the new standard of care and production method for flu vaccines. \n\nBear case is dead and has been since I first bought at $3.50 in October 2019", "score": 1, "replies": [{"body": "[https://www.reuters.com/business/healthcare-pharmaceuticals/exclusive-novavax-delays-eu-vaccine-supply-deal-amid-production-problems-source-2021-03-25/](https://www.reuters.com/business/healthcare-pharmaceuticals/exclusive-novavax-delays-eu-vaccine-supply-deal-amid-production-problems-source-2021-03-25/)\n\nBut hey, what do they know. Surely you know better than the NVAX executive.", "score": 1, "replies": [{"body": "The flu vaccine is the real key here... not Covid like all the hype boys think \n\nNew production method. Long term share holders = money. It‚Äôll get ironed out and whatnot. They only expected to produce flu vaccines about a year ago and now they have that + Covid. Takeda is also helping produce \n\nBuying calls... bad idea. Too volatile. Long dated leaps maybe or shares = pay day", "score": 1, "replies": []}]}]}]}]}]}, {"body": "I didn't read this but Novavax has never successfully made a vaccine. I'm probably more retarded than you and therefore have the better play here. Puts on nvax all in on gourd futures\n\nEdit: give me awards", "score": 0, "replies": [{"body": "Precisely why I think first approval will be such a big deal! With how volatile this stock is you may get lucky with your puts (of course I think you‚Äôd have more luck with calls üòú)", "score": 3, "replies": [{"body": "I hope you do well! I got burned on nvax last summer but hope they pull this out", "score": 2, "replies": []}]}, {"body": "This aged well.", "score": 2, "replies": [{"body": "lmao whoops", "score": 1, "replies": []}]}]}, {"body": "Only place NVAX is going to is Puthalla.", "score": -2, "replies": [{"body": "Lolz", "score": 1, "replies": []}]}, {"body": "Looks like they will be too late to the party to make any money. BioNTech and Moderna are hovering up all the deals.", "score": 1, "replies": [{"body": "I still disagree! They‚Äôre about to turn the corner and begin actually profiting with covid, nanoflu, malaria, and rsv. On top of that they will still sign a deal with the EU if that‚Äôs what you‚Äôre referencing. Staying strong! Though I am upset at their PR team for not mitigating this fud at all", "score": 2, "replies": [{"body": "Sounds like Hopium my friend..\n\nBioNTech and Moderna both have deals for 500M+ vaccines to India and EU. \n\nMeanwhile NVAX still delayed. It‚Äôs game over.", "score": 2, "replies": [{"body": "People like you always come out of the woodwork on red days lol. Just let me do me, join if you want or if you‚Äôre so sure it‚Äôs over then short it.\n\nIt‚Äôs not hopium, it‚Äôs conviction. I‚Äôve read the financials, I‚Äôve read the scientific papers, I‚Äôve done the math on expected revenue and potential stock prices given a particular P/S ratio. It‚Äôs my personal *speculation* that this company has lots of potential still. And not just for covid. If I sold anytime NVAX FUD was spread I would never have made money in 2020.", "score": 3, "replies": [{"body": "Beware of confirmation bias. \n\nLots of smart people working hard over at BioNTech and Moderna. \n\nDon‚Äôt fight the tape.\n\nEdit: the correct phrase is ‚Äúdon‚Äôt argue with the tape‚Äù.", "score": 2, "replies": []}]}]}]}]}]}
{"title": "[deleted by user]", "selftext": "[removed]", "id": "mvnclb", "created_utc": 1619033253.0, "score": 332, "upvote_ratio": 0.81, "num_comments": 61, "comments": [{"body": "Have you sold? If so, congrats and fuck you.", "score": 118, "replies": []}, {"body": "if it's good enough to post TWICE it's good enough to sell!!  Congrats!", "score": 70, "replies": []}, {"body": "Fucking nicely done! Take the money and run!!!", "score": 41, "replies": []}, {"body": "Sell the initial 62k nut and then let it ride!", "score": 43, "replies": [{"body": "This is the way", "score": 11, "replies": []}, {"body": "What about tax", "score": -7, "replies": [{"body": "You have all year to lose it before taxes.", "score": 65, "replies": [{"body": "This is the way", "score": 9, "replies": []}]}, {"body": "If you let it ride and then lose it all you won‚Äôt owe any taxes. You only owe taxes if you have a capital *gain*", "score": 8, "replies": []}, {"body": "Who cares. Make them come after you then settle for a 1/4 of the tax you were supposed to pay. This is how a 35% tax becomes a 8% tax.", "score": -1, "replies": [{"body": "[deleted]", "score": 18, "replies": [{"body": "I like how his wrinkled brain works. This. Is. The. Way.", "score": 4, "replies": [{"body": "[deleted]", "score": 2, "replies": [{"body": "You got your CPA License? I‚Äôd love to talk to another fellow retard, but only if you‚Äôre a qualified retard with full certifications.", "score": 2, "replies": []}]}]}]}, {"body": "Uh wait. How do I go about reaching a settlement with the IRS? Asking for a friend.", "score": 8, "replies": [{"body": "[https://www.optimataxrelief.com/](https://www.optimataxrelief.com/)", "score": 5, "replies": []}]}]}]}]}, {"body": "Congrats and fuck you", "score": 6, "replies": [{"body": "Thank you sir and fuck you back very much", "score": 13, "replies": [{"body": "Now kiss.", "score": 16, "replies": []}]}]}, {"body": "I grabbed 10 700C for May at the bottom of the dip, but jumped out at 720ish. I can't be too mad, but def pulled out early and left another 10K on the table for the day. Just started screwing around with my retirement acct and didn't want to miss gains. Need some more wins and then I can be a little looser with the profit.", "score": 4, "replies": []}, {"body": "Pay your taxes. Anybody that says otherwise is just being stupid.", "score": 8, "replies": []}, {"body": "Congrats and fuck you.", "score": 2, "replies": []}, {"body": "Truly autistic. A real YOLO", "score": 2, "replies": []}, {"body": "[deleted]", "score": 1, "replies": [{"body": "What is a loser? What is a sell? I only buy", "score": 14, "replies": []}]}, {"body": "I have a similar (albeit much smaller) call position.  I am going to sell on Monday if it's far in the money.  If not, I'm going to let it ride and see if earnings are as good as I think they will be", "score": 0, "replies": []}, {"body": "you should of bought some ISRG calls today instead, you would have made 160-460% profit", "score": -2, "replies": []}, {"body": "Smooth brain here. Does that mean you paid $12 and change per share??", "score": -17, "replies": [{"body": "That means they paid $1200+ per contract.", "score": 9, "replies": []}, {"body": "https://www.google.com/search?q=stock+options", "score": 3, "replies": []}, {"body": "Idk why you're getting down voted. He bought 40 contracts at a 12.68 strike price. He spent $12.68 per share for the right to buy  all 40,000 of them.", "score": -8, "replies": [{"body": "His strike is 715, not 12.68", "score": 8, "replies": [{"body": "715 wouldn't give him a 125% return though. Maybe I'm just reading the screanshot wrong.", "score": 0, "replies": [{"body": "I‚Äôm not exactly sure what you mean? He bought 715 strike calls expiring 4/23 for 12.68 premium. Now that premium is worth 28.12- a 121.85% gain. \n\nYou are confusing words with different numbers. Are you newly learning options ?", "score": 1, "replies": [{"body": "I'm mixing up strike and premium I guess. Not new just always called the premium the strike price. Self taught retard.", "score": 1, "replies": []}]}]}]}, {"body": "That's a question for r/options, not here.", "score": 4, "replies": []}, {"body": "Thanks!", "score": 1, "replies": []}]}]}, {"body": "[deleted]", "score": -8, "replies": [{"body": "You must be the 2021 Homo Retard  CuckoldüñïFYI, Between those 2 posts I have also fucked your wife and made another 50+ trades. Isnt it even more ‚Äúsuspicious‚Äù?üí∏üí∏üñïüñï", "score": 21, "replies": [{"body": "Some people just don‚Äôt get it", "score": 2, "replies": []}, {"body": "[deleted]", "score": 1, "replies": [{"body": "Upper part is my username you fuckface...but thanks for the comment üñï", "score": 0, "replies": []}, {"body": "or maybe he is a TA dude and is just following the trends...", "score": 1, "replies": []}]}]}, {"body": "But thank you sir üòâ", "score": 3, "replies": []}]}, {"body": "Weak comments make them hands stronger, we ain‚Äôt sellin", "score": -4, "replies": []}, {"body": "This mans...", "score": 1, "replies": []}, {"body": "congrats!!!!!", "score": 1, "replies": []}, {"body": "Dang dude that‚Äôs hot", "score": 1, "replies": []}, {"body": "So you fuck, huh?", "score": 1, "replies": [{"body": "So you suck huh? ü•≥", "score": 2, "replies": [{"body": "Only behind Wendy‚Äôs on the third Sunday of the odd number months.", "score": 7, "replies": [{"body": "See ya üòú", "score": 0, "replies": []}]}]}]}, {"body": "Like a boss... good job. Now sell that shit and keep the profits for a new model S.", "score": 1, "replies": []}, {"body": "Scared money don‚Äôt make money...", "score": 1, "replies": []}, {"body": "Damn, even higher today. You still holding on to some of those?", "score": 1, "replies": []}]}
